Hospitals in New York City are preparing to use the blood of recovered COVID-19 patients as a potential treatment, leveraging a century-old method that infuses patients with antibody-rich blood. Preliminary studies from China suggest this approach may offer benefits, raising questions about its effectiveness. Meanwhile, personal anecdotes highlight the challenges of quarantine and health anxieties during the pandemic.
